Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

Overview
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

15-LOX-catalytic bias towards ether-(alkenyl)-ETE-PEs oxidation bestows selectivity of PRO-ferroptotic cell death signaling.

Nature communications·2026
Same author

Current Clinical Utility of Gene Expression Panels in Primary Cutaneous Melanoma.

Cancers·2026
Same author

Expert opinion on burning questions in cancer myeloid cell biology.

Journal for immunotherapy of cancer·2026
Same author

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

Nature communications·2026
Same author

Harnessing myeloid cell plasticity for cancer therapy.

Nature cancer·2026
Same author

A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma.

Cell reports. Medicine·2026

Related Experiment Video

Updated: Jun 11, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Lipid accumulation and dendritic cell dysfunction in cancer.

Donna L Herber1, Wei Cao, Yulia Nefedova

  • 1Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.

Nature Medicine
|July 13, 2010
PubMed
Summary

Cancer immunotherapy can be improved by targeting lipid accumulation in dendritic cells (DCs). Reducing triglyceride levels in these immune cells restores their function and enhances cancer vaccine efficacy.

Related Experiment Videos

Last Updated: Jun 11, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Dendritic cells (DCs) are crucial for initiating and maintaining immune responses.
  • Immune dysfunction is a hallmark of the tumor microenvironment.

Purpose of the Study:

  • To investigate the role of lipid accumulation in dendritic cells (DCs) in cancer.
  • To explore therapeutic strategies for enhancing anti-tumor immunity by modulating DC lipid content.

Main Methods:

  • Analysis of lipid levels in DCs from tumor-bearing and tumor-free subjects.
  • Assessment of DC function, including T cell stimulation and antigen presentation.
  • Pharmacological inhibition of lipid accumulation using acetyl-CoA carboxylase inhibitors.

Main Results:

  • Dendritic cells in tumor-bearing individuals exhibit significantly higher triglyceride levels.
  • Lipid-laden DCs show impaired T cell stimulation and antigen processing capabilities.
  • Inhibiting lipid accumulation in DCs restores their function and enhances cancer vaccine effectiveness.

Conclusions:

  • Elevated lipid levels in DCs impair anti-tumor immune responses.
  • Pharmacological targeting of DC lipid metabolism represents a promising strategy for cancer immunotherapy.
  • Modulating DC lipid content can improve the efficacy of cancer vaccines.